3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
44
Breast Neoplasms
30
Lymphoma
29
Sarcoma
27
Hodgkin Disease
24
Triple Negative Breast Neoplasms
20
Burkitt Lymphoma
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Neoplasms
15
Lymphoma, Follicular
15
Ovarian Neoplasms
14
Lymphoma, B-Cell
14
Lymphoma, Non-Hodgkin
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, T-Cell, Peripheral
9
Endometrial Neoplasms
9
Neuroblastoma
7
Neoplasm Metastasis
7
Lymphoma, Mantle-Cell
7
Liposarcoma
7
Leukemia
7
Fallopian Tube Neoplasms
7
Recurrence
6
Multiple Myeloma
6
Leiomyosarcoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Osteosarcoma
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Inflammatory Breast Neoplasms
5
Interventions
Carboplatin
47
Etoposide
46
durvalumab
28
atezolizumab
27
Cisplatin
21
Topotecan
19
pembrolizumab
15
PM 01183
15
Nivolumab
12
Specimen Handling
11
Drug Therapy
10
anlotinib
9
Radiotherapy
9
Paclitaxel
9
Temozolomide
8
Magnetic Resonance Spectroscopy
8
AMG 757
8
Radiosurgery
7
Platinum
7
Irinotecan
7
toripalimab
6
olaparib
6
Biopsy
6
Ipilimumab
5
Injections
5
Docetaxel
5
Bevacizumab
5
trilaciclib
4
tremelimumab
4
tislelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Doxorubicin
×
1 year
×
Clear all
No trials found.